First Patient Treated in Phase 2 GvHD Trial ...Middle East

PR Newswire - News
First Patient Treated in Phase 2 GvHD Trial
MELBOURNE, Australia, March 4, 2024 /PRNewswire/ -- Cynata Therapeutics Limited (ASX: "CYP", "Cynata", or the "Company"), a clinical-stage biotechnology company specialising in cell therapeutics, confirms that the first patient has been enrolled and treated in its Phase 2 clinical trial...

Hence then, the article about first patient treated in phase 2 gvhd trial was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( First Patient Treated in Phase 2 GvHD Trial )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News